Patents by Inventor Daniel Barkan

Daniel Barkan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PREDICTING BLADDER CANCER RESPONSIVENESS TO BCG
    Publication number: 20150185224
    Abstract: Bacillus Calmette-Guerin (BCG) administration plays a central role in managing carcinoma in situ of the bladder. Unfortunately, recurrence or progression of disease is seen in up to 30% of treated patients. Disclosed herein is a method for predicting responsiveness to treatment with BCG based on BCG internalization by bladder cancer cells, the presence or absence of mutations associated with BCG uptake or a combination thereof.
    Type: Application
    Filed: August 7, 2013
    Publication date: July 2, 2015
    Applicant: MEMORIAL SLOAN-KETTERING CANCER CENTER
    Inventors: Michael Glickman, Xuejun Jiang, Daniel Barkan, Gil Redelman-Sidi, Gopa Iyer, David Solit, Bernard H. Bochner
  • Methods for the treatment of renal failure
    Patent number: 7897145
    Abstract: The present invention relates to methods for treating renal failure. Particularly, the present invention relates to methods for treating renal failure by administering to a subject complexes that include a member of the IL-6 family linked to a soluble receptor of the member of the IL-6 family, or isolated polynucleotides encoding same, the complexes capable of activating a gp130 mediated signaling pathway, thereby treating acute or chronic renal failure.
    Type: Grant
    Filed: June 15, 2006
    Date of Patent: March 1, 2011
    Assignee: Hadasit Medical Research Services and Development Ltd.
    Inventors: Jonathan Axelrod, Daniel Barkan, Eithan Galun, Yael Nehemia, Stefan Rose-John
  • METHODS FOR THE TREATMENT OF RENAL FAILURE
    Publication number: 20100135952
    Abstract: The present invention relates to methods for treating renal failure. Particularly, the present invention relates to methods for treating renal failure by administering to a subject complexes that include a member of the IL-6 family linked to a soluble receptor of the member of the IL-6 family, or isolated polynucleotides encoding same, the complexes capable of activating a gp130 mediated signaling pathway, thereby treating acute or chronic renal failure.
    Type: Application
    Filed: June 15, 2006
    Publication date: June 3, 2010
    Inventors: Jonathan Axelrod, Daniel Barkan, Eithan Galun, Yael Nehemia, Stefan Rose-John